{"transactions":[{"id":2060189,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T17:37:34.000Z","date":"2023-01-04","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in full on the date of the Issuer's annual meeting of stockholders in 2023 or any special meeting held in lieu thereof, provided the Reporting Person provides continuous service to the Issuer through such date."}],"balance_after":6000,"derivative":{"exercise_price":2.7183,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001474506-23-000012","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000147450623000012/primary_doc.xml","form_type":"4"}},{"id":2524407,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-04T20:32:11.000Z","date":"2021-11-02","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in full on June 15, 2022, provided the Reporting Person provides continuous service to the Issuer through such date."}],"balance_after":6000,"derivative":{"exercise_price":4.05,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001474506-21-000163","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000147450621000163/primary_doc.xml","form_type":"4"}},{"id":2565416,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-17T16:49:56.000Z","date":"2021-09-17","kind":"other","acquired":true,"shares":215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of shares by One Partner Square Associates VI, LLC to its members."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of shares by One Partner Square Associates VI, LLC to its members."}],"balance_after":327,"source":{"system":"sec-edgar","filing":"0000904454-21-000668","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000090445421000668/edgar.xml","form_type":"4"}},{"id":3102954,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-22T16:39:27.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over twelve months, beginning one month after the date of grant, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."}],"balance_after":3333,"derivative":{"exercise_price":6.7,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0000904454-20-000413","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000090445420000413/edgar.xml","form_type":"4"}},{"id":3443877,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2019-08-08T16:23:15.000Z","date":"2019-08-06","kind":"purchase","acquired":true,"shares":187500,"price":4,"value":750000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased as Units, each Unit consisting of one share of Common Stock and a Warrant to purchase 0.75 of one share of Common Stock, at a purchase price of $4.00 per Unit."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":187500,"derivative":{"exercise_price":4.4,"exercise_date":"2019-08-06","expiration_date":"2024-08-06","underlying":"Common Stock","underlying_shares":187500},"source":{"system":"sec-edgar","filing":"0000904454-19-000600","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445419000600/edgar.xml","form_type":"4"}},{"id":3443876,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-08T16:23:15.000Z","date":"2019-08-06","kind":"purchase","acquired":true,"shares":250000,"price":4,"value":1000000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased as Units, each Unit consisting of one share of Common Stock and a Warrant to purchase 0.75 of one share of Common Stock, at a purchase price of $4.00 per Unit."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported ownership reflects the one-for-ten reverse split of the Common Stock effected on July 24, 2019."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"As managing members of One Palmer Square Associates VII, LLC, which is also the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own 4,957 shares of Common Stock held by DP VII Associates, L.P."}],"balance_after":813433,"source":{"system":"sec-edgar","filing":"0000904454-19-000600","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445419000600/edgar.xml","form_type":"4"}},{"id":3481135,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T16:16:05.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over twelve months, beginning one month after the date of grant, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."}],"balance_after":50000,"derivative":{"exercise_price":0.92,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000904454-19-000515","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000090445419000515/edgar.xml","form_type":"4"}},{"id":3772333,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-06T16:16:07.000Z","date":"2018-11-06","kind":"sale","acquired":false,"shares":11,"price":14.16,"value":155.76,"ownership":{"direct":false,"nature":"By DP VIII Associates, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.90 to $14.28. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":19150,"source":{"system":"sec-edgar","filing":"0000904454-18-000702","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000702/edgar.xml","form_type":"4"}},{"id":3772332,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-06T16:16:07.000Z","date":"2018-11-06","kind":"sale","acquired":false,"shares":1489,"price":14.16,"value":21084.24,"ownership":{"direct":false,"nature":"By Domain Partners VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.90 to $14.28. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":2586535,"source":{"system":"sec-edgar","filing":"0000904454-18-000702","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000702/edgar.xml","form_type":"4"}},{"id":3772331,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-06T16:16:07.000Z","date":"2018-11-06","kind":"sale","acquired":false,"shares":761,"price":13.18,"value":10029.98,"ownership":{"direct":false,"nature":"By DP VIII Associates, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.899. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":19161,"source":{"system":"sec-edgar","filing":"0000904454-18-000702","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000702/edgar.xml","form_type":"4"}},{"id":3772330,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-06T16:16:07.000Z","date":"2018-11-06","kind":"sale","acquired":false,"shares":102067,"price":13.18,"value":1345243.06,"ownership":{"direct":false,"nature":"By Domain Partners VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.899. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":2588024,"source":{"system":"sec-edgar","filing":"0000904454-18-000702","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000702/edgar.xml","form_type":"4"}},{"id":3772329,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-06T16:16:07.000Z","date":"2018-11-05","kind":"sale","acquired":false,"shares":295,"price":12.98,"value":3829.1,"ownership":{"direct":false,"nature":"By DP VIII Associates, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.37. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":19922,"source":{"system":"sec-edgar","filing":"0000904454-18-000702","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000702/edgar.xml","form_type":"4"}},{"id":3772328,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-06T16:16:07.000Z","date":"2018-11-05","kind":"sale","acquired":false,"shares":39606,"price":12.98,"value":514085.88,"ownership":{"direct":false,"nature":"By Domain Partners VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.37. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":2690091,"source":{"system":"sec-edgar","filing":"0000904454-18-000702","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000702/edgar.xml","form_type":"4"}},{"id":3772327,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-06T16:16:07.000Z","date":"2018-11-02","kind":"sale","acquired":false,"shares":1412,"price":13.47,"value":19019.64,"ownership":{"direct":false,"nature":"By DP VIII Associates, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.01 to $13.88. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":20217,"source":{"system":"sec-edgar","filing":"0000904454-18-000702","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000702/edgar.xml","form_type":"4"}},{"id":3772326,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-06T16:16:07.000Z","date":"2018-11-02","kind":"sale","acquired":false,"shares":189359,"price":13.47,"value":2550665.73,"ownership":{"direct":false,"nature":"By Domain Partners VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.01 to $13.88. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":2729697,"source":{"system":"sec-edgar","filing":"0000904454-18-000702","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000702/edgar.xml","form_type":"4"}},{"id":3773894,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-11-05T10:05:53.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":1408,"price":13.37,"value":18824.96,"ownership":{"direct":false,"nature":"By DP VIII Associates, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.04 to $13.59. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":21629,"source":{"system":"sec-edgar","filing":"0000904454-18-000697","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000697/edgar.xml","form_type":"4/A","original_submission_date":"2018-11-01"}},{"id":3773893,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-11-05T10:05:53.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":188867,"price":13.37,"value":2525151.79,"ownership":{"direct":false,"nature":"By Domain Partners VIII, L.P."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"This amendment is being filed solely to correct a typographical error in this share number as reported in the Form 4 filed on November 1, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.04 to $13.59. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":2919056,"source":{"system":"sec-edgar","filing":"0000904454-18-000697","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000697/edgar.xml","form_type":"4/A","original_submission_date":"2018-11-01"}},{"id":3773892,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-11-05T10:05:53.000Z","date":"2018-10-31","kind":"sale","acquired":false,"shares":959,"price":13.6,"value":13042.4,"ownership":{"direct":false,"nature":"By DP VIII Associates, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $14.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":23037,"source":{"system":"sec-edgar","filing":"0000904454-18-000697","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000697/edgar.xml","form_type":"4/A","original_submission_date":"2018-11-01"}},{"id":3773891,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-11-05T10:05:53.000Z","date":"2018-10-31","kind":"sale","acquired":false,"shares":128670,"price":13.6,"value":1749912.0,"ownership":{"direct":false,"nature":"By Domain Partners VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $14.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":3107923,"source":{"system":"sec-edgar","filing":"0000904454-18-000697","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000697/edgar.xml","form_type":"4/A","original_submission_date":"2018-11-01"}},{"id":3773890,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-11-05T10:05:53.000Z","date":"2018-10-30","kind":"sale","acquired":false,"shares":678,"price":14.31,"value":9702.18,"ownership":{"direct":false,"nature":"By DP VIII Associates, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.25 to $14.46. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":23996,"source":{"system":"sec-edgar","filing":"0000904454-18-000697","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000697/edgar.xml","form_type":"4/A","original_submission_date":"2018-11-01"}},{"id":3773889,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-11-05T10:05:53.000Z","date":"2018-10-30","kind":"sale","acquired":false,"shares":90918,"price":14.31,"value":1301036.58,"ownership":{"direct":false,"nature":"By Domain Partners VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.25 to $14.46. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":3236593,"source":{"system":"sec-edgar","filing":"0000904454-18-000697","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000697/edgar.xml","form_type":"4/A","original_submission_date":"2018-11-01"}},{"id":3773888,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-11-05T10:05:53.000Z","date":"2018-10-30","kind":"sale","acquired":false,"shares":1136,"price":13.68,"value":15540.48,"ownership":{"direct":false,"nature":"By DP VIII Associates, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.26 to $14.2499. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":24674,"source":{"system":"sec-edgar","filing":"0000904454-18-000697","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000697/edgar.xml","form_type":"4/A","original_submission_date":"2018-11-01"}},{"id":3773887,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-11-05T10:05:53.000Z","date":"2018-10-30","kind":"sale","acquired":false,"shares":152364,"price":13.68,"value":2084339.52,"ownership":{"direct":false,"nature":"By Domain Partners VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.26 to $14.2499. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":3327511,"source":{"system":"sec-edgar","filing":"0000904454-18-000697","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000697/edgar.xml","form_type":"4/A","original_submission_date":"2018-11-01"}},{"id":3777917,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-01T18:08:51.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":1408,"price":13.37,"value":18824.96,"ownership":{"direct":false,"nature":"By DP VIII Associates, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.04 to $13.59. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":21629,"source":{"system":"sec-edgar","filing":"0000904454-18-000691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000691/edgar.xml","form_type":"4"}},{"id":3777916,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-01T18:08:51.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":188167,"price":13.37,"value":2515792.79,"ownership":{"direct":false,"nature":"By Domain Partners VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.04 to $13.59. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":2919056,"source":{"system":"sec-edgar","filing":"0000904454-18-000691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000691/edgar.xml","form_type":"4"}},{"id":3777915,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-01T18:08:51.000Z","date":"2018-10-31","kind":"sale","acquired":false,"shares":959,"price":13.6,"value":13042.4,"ownership":{"direct":false,"nature":"By DP VIII Associates, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $14.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":23037,"source":{"system":"sec-edgar","filing":"0000904454-18-000691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000691/edgar.xml","form_type":"4"}},{"id":3777914,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-01T18:08:51.000Z","date":"2018-10-31","kind":"sale","acquired":false,"shares":128670,"price":13.6,"value":1749912.0,"ownership":{"direct":false,"nature":"By Domain Partners VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $14.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":3107923,"source":{"system":"sec-edgar","filing":"0000904454-18-000691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000691/edgar.xml","form_type":"4"}},{"id":3777913,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-01T18:08:51.000Z","date":"2018-10-30","kind":"sale","acquired":false,"shares":678,"price":14.31,"value":9702.18,"ownership":{"direct":false,"nature":"By DP VIII Associates, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.25 to $14.46. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":23996,"source":{"system":"sec-edgar","filing":"0000904454-18-000691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000691/edgar.xml","form_type":"4"}},{"id":3777912,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-01T18:08:51.000Z","date":"2018-10-30","kind":"sale","acquired":false,"shares":90918,"price":14.31,"value":1301036.58,"ownership":{"direct":false,"nature":"By Domain Partners VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.25 to $14.46. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":3236593,"source":{"system":"sec-edgar","filing":"0000904454-18-000691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000691/edgar.xml","form_type":"4"}},{"id":3777911,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-01T18:08:51.000Z","date":"2018-10-30","kind":"sale","acquired":false,"shares":1136,"price":13.68,"value":15540.48,"ownership":{"direct":false,"nature":"By DP VIII Associates, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.26 to $14.2499. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":24674,"source":{"system":"sec-edgar","filing":"0000904454-18-000691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000691/edgar.xml","form_type":"4"}},{"id":3777910,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-01T18:08:51.000Z","date":"2018-10-30","kind":"sale","acquired":false,"shares":152364,"price":13.68,"value":2084339.52,"ownership":{"direct":false,"nature":"By Domain Partners VIII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.26 to $14.2499. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":3327511,"source":{"system":"sec-edgar","filing":"0000904454-18-000691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000691/edgar.xml","form_type":"4"}},{"id":3833141,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T17:32:26.000Z","date":"2018-08-23","kind":"purchase","acquired":true,"shares":1648359,"price":1.82,"value":3000013.38,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of One Palmer Square Associates VII, LLC, which is also the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own 49,908 shares of Common Stock held by DP VII Associates, L.P."}],"balance_after":5634329,"source":{"system":"sec-edgar","filing":"0000904454-18-000526","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000526/edgar.xml","form_type":"4"}},{"id":3833140,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"price":0,"reported_value":11048,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $11,048. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"reported_value","element":"transactionTotalValue","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $11,048. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $11,048. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $11,048. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $11,048. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"exercise_price":4.59,"underlying":"Common Stock","underlying_shares":2505},"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833139,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D-1 Preferred Stock","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":27328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":638},"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833138,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":47460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1109},"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833137,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":40268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":941},"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833136,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":22161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":518},"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833135,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":50532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1180},"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833134,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":true,"shares":2505,"price":4.59,"value":11497.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $11,048. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":6891,"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833133,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T17:20:40.000Z","date":"2018-08-23","kind":"exercise","acquired":true,"shares":4386,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":4386,"source":{"system":"sec-edgar","filing":"0000904454-18-000524","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000524/edgar.xml","form_type":"4"}},{"id":3833125,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"purchase","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Common Stock and Warrants to Purchase Common Stock were issued and sold as units at a purchase price of $6.125 per unit.  Each unit consists of one share of Common Stock and one Warrant to purchase one share of Common Stock.  The units will separate, and the underlying Common Stock and Warrants will begin trading separately, no later than 30 days following the date of the IPO prospectus, at which time the Warrants will become exercisable for a period of five years."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Common Stock and Warrants to Purchase Common Stock were issued and sold as units at a purchase price of $6.125 per unit.  Each unit consists of one share of Common Stock and one Warrant to purchase one share of Common Stock.  The units will separate, and the underlying Common Stock and Warrants will begin trading separately, no later than 30 days following the date of the IPO prospectus, at which time the Warrants will become exercisable for a period of five years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Common Stock and Warrants to Purchase Common Stock were issued and sold as units at a purchase price of $6.125 per unit.  Each unit consists of one share of Common Stock and one Warrant to purchase one share of Common Stock.  The units will separate, and the underlying Common Stock and Warrants will begin trading separately, no later than 30 days following the date of the IPO prospectus, at which time the Warrants will become exercisable for a period of five years."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":15000,"derivative":{"exercise_price":6.125,"exercise_date":"2018-09-20","expiration_date":"2023-09-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833124,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"price":0,"reported_value":1488952,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $1,488,952. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"reported_value","element":"transactionTotalValue","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $1,488,952. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $1,488,952. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $1,488,952. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $1,488,952. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"exercise_price":4.59,"underlying":"Common Stock","underlying_shares":337694},"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833123,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D-1 Preferred Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":3682919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":86050},"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833122,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":6396105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":149441},"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833121,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":5426808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":126794},"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833120,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":2986762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":69784},"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833119,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":6810098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":159115},"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833118,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"purchase","acquired":true,"shares":15000,"price":6.125,"value":91875.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Common Stock and Warrants to Purchase Common Stock were issued and sold as units at a purchase price of $6.125 per unit.  Each unit consists of one share of Common Stock and one Warrant to purchase one share of Common Stock.  The units will separate, and the underlying Common Stock and Warrants will begin trading separately, no later than 30 days following the date of the IPO prospectus, at which time the Warrants will become exercisable for a period of five years."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":943878,"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833117,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":true,"shares":337694,"price":4.59,"value":1550015.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $1,488,952. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the \"Conversion Amount\") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 75% of the IPO price per share of $6.125 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":929878,"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3833116,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T17:03:03.000Z","date":"2018-08-23","kind":"exercise","acquired":true,"shares":591184,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the \"IPO\"), for no additional consideration. The Preferred Stock had no expiration date"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Partner Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":591184,"source":{"system":"sec-edgar","filing":"0000904454-18-000522","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445418000522/edgar.xml","form_type":"4"}},{"id":3883854,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-25T16:53:16.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly over 12 months from June 21, 2018 (\"Grant Date\") in substantially equal monthly installments, provided that the option will vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each such date or, if earlier, such annual meeting."}],"balance_after":25000,"derivative":{"exercise_price":13.08,"expiration_date":"2028-06-21","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000904454-18-000439","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000439/edgar.xml","form_type":"4"}},{"id":3885965,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-21T16:37:49.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over twelve months, beginning one month after the date of grant, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":0.86,"expiration_date":"2028-06-18","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000904454-18-000437","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000090445418000437/edgar.xml","form_type":"4"}},{"id":3898068,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2018-06-11T16:12:24.000Z","date":"2018-06-07","kind":"exercise","acquired":false,"shares":156,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By DP VIII Associates, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":0,"derivative":{"exercise_price":7,"exercise_date":"2014-01-29","expiration_date":"2018-06-26","underlying":"Common Stock","underlying_shares":156},"source":{"system":"sec-edgar","filing":"0000904454-18-000422","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000422/edgar.xml","form_type":"4"}},{"id":3898067,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2018-06-11T16:12:24.000Z","date":"2018-06-07","kind":"exercise","acquired":false,"shares":21041,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Domain Partners VIII, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":0,"derivative":{"exercise_price":7,"exercise_date":"2014-01-29","expiration_date":"2018-06-26","underlying":"Common Stock","underlying_shares":21041},"source":{"system":"sec-edgar","filing":"0000904454-18-000422","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000422/edgar.xml","form_type":"4"}},{"id":3898066,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-11T16:12:24.000Z","date":"2018-06-07","kind":"tax_withholding","acquired":false,"shares":76,"price":14.45,"value":1098.2,"ownership":{"direct":false,"nature":"By DP VIII Associates, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":25810,"source":{"system":"sec-edgar","filing":"0000904454-18-000422","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000422/edgar.xml","form_type":"4"}},{"id":3898065,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-11T16:12:24.000Z","date":"2018-06-07","kind":"tax_withholding","acquired":false,"shares":10195,"price":14.45,"value":147317.75,"ownership":{"direct":false,"nature":"By Domain Partners VIII, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":3479875,"source":{"system":"sec-edgar","filing":"0000904454-18-000422","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000422/edgar.xml","form_type":"4"}},{"id":3898064,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-11T16:12:24.000Z","date":"2018-06-07","kind":"exercise","acquired":true,"shares":156,"price":7,"value":1092.0,"ownership":{"direct":false,"nature":"By DP VIII Associates, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":25886,"source":{"system":"sec-edgar","filing":"0000904454-18-000422","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000422/edgar.xml","form_type":"4"}},{"id":3898063,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-11T16:12:24.000Z","date":"2018-06-07","kind":"exercise","acquired":true,"shares":21041,"price":7,"value":147287.0,"ownership":{"direct":false,"nature":"By Domain Partners VIII, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him."}],"balance_after":3490070,"source":{"system":"sec-edgar","filing":"0000904454-18-000422","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445418000422/edgar.xml","form_type":"4"}},{"id":4125374,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Redeemable Convertible Preferred Stock","published_at":"2017-12-20T16:51:02.000Z","date":"2017-12-18","kind":"exercise","acquired":false,"shares":368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Redeemable Convertible Preferred Stock was immediately convertible upon its purchase on 04/11/2017, subject to certain conditions.  The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Redeemable Convertible Preferred Stock was immediately convertible upon its purchase on 04/11/2017, subject to certain conditions.  The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each share of Redeemable Convertible Preferred Stock had a stated value of $100 (the \"Stated Value\") and accrued dividends daily at an initial rate of 12% per annum, which was reduced to 8% per annum on October 28, 2017 in accordance with the Certificate of Designations for the Redeemable Convertible Preferred Stock. The Stated Value, as adjusted to give effect to such dividends, was referred to as the \"Accrued Value.\" Each share of Redeemable Convertible Preferred Stock was convertible, at the option of the holder or, upon the occurrence of certain events, at the option of the Issuer, and subject to certain conditions, into a number of shares of Common Stock determined by dividing the Accrued Value by the conversion price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"exercise_price":3.19,"underlying":"Common Stock","underlying_shares":12444},"source":{"system":"sec-edgar","filing":"0000904454-17-000741","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000741/edgar.xml","form_type":"4"}},{"id":4125373,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-20T16:51:02.000Z","date":"2017-12-18","kind":"grant","acquired":true,"shares":282,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person received an additional 282 shares of Common Stock from the Issuer, representing the additional dividend accruals on the Redeemable Convertible Preferred Stock that the Reporting Person would have been entitled to receive up to and including March 31, 2018."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":25730,"source":{"system":"sec-edgar","filing":"0000904454-17-000741","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000741/edgar.xml","form_type":"4"}},{"id":4125372,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-20T16:51:02.000Z","date":"2017-12-18","kind":"exercise","acquired":true,"shares":12444,"price":3.19,"value":39696.36,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":25448,"source":{"system":"sec-edgar","filing":"0000904454-17-000741","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000741/edgar.xml","form_type":"4"}},{"id":4125371,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Redeemable Convertible Preferred Stock","published_at":"2017-12-20T16:48:32.000Z","date":"2017-12-18","kind":"exercise","acquired":false,"shares":49632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Redeemable Convertible Preferred Stock was immediately convertible upon its purchase on 04/11/2017, subject to certain conditions. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Redeemable Convertible Preferred Stock was immediately convertible upon its purchase on 04/11/2017, subject to certain conditions. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each share of Redeemable Convertible Preferred Stock had a stated value of $100 (the \"Stated Value\") and accrued dividends daily at an initial rate of 12% per annum, which was reduced to 8% per annum on October 28, 2017 in accordance with the Certificate of Designations for the Redeemable Convertible Preferred Stock. The Stated Value, as adjusted to give effect to such dividends, was referred to as the \"Accrued Value.\" Each share of Redeemable Convertible Preferred Stock was convertible, at the option of the holder or, upon the occurrence of certain events, at the option of the Issuer, and subject to certain conditions, into a number of shares of Common Stock determined by dividing the Accrued Value by the conversion price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"derivative":{"exercise_price":3.19,"underlying":"Common Stock","underlying_shares":1678432},"source":{"system":"sec-edgar","filing":"0000904454-17-000739","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000739/edgar.xml","form_type":"4"}},{"id":4125370,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-20T16:48:32.000Z","date":"2017-12-18","kind":"grant","acquired":true,"shares":37890,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person received an additional 37,890 shares of Common Stock from the Issuer, representing the additional dividend accruals on the Redeemable Convertible Preferred Stock that the Reporting Person would have been entitled to receive up to and including March 31, 2018."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":3469029,"source":{"system":"sec-edgar","filing":"0000904454-17-000739","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000739/edgar.xml","form_type":"4"}},{"id":4125369,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-20T16:48:32.000Z","date":"2017-12-18","kind":"exercise","acquired":true,"shares":1678432,"price":3.19,"value":5354198.08,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":3431139,"source":{"system":"sec-edgar","filing":"0000904454-17-000739","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000739/edgar.xml","form_type":"4"}},{"id":4133794,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":164155,"kind":"organization","name":"DOMAIN ASSOCIATES","position":1,"cik":"0001020733","reported_name":"DOMAIN ASSOCIATES","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":7,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-13T16:58:46.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":47963,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-17-000727","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000727/edgar.xml","form_type":"4"}},{"id":4133789,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-13T16:38:43.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":7333,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-17-000720","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000720/edgar.xml","form_type":"4"}},{"id":4133788,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-13T16:32:14.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":988285,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between the Issuer, MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into the Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares Common Stock of the Issuer outstanding immediately prior to the effective time of the Merger were canceled and converted automatically into the right to receive (i) $1.52 per share in cash, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt, entered into on December 7, 2017, to receive one or more payments in cash currently estimated to be up to $2.58 per share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-17-000718","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000718/edgar.xml","form_type":"4"}},{"id":4253811,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-20T16:02:22.000Z","date":"2017-07-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests monthly over 12 months from July 11, 2017, in substantially equal monthly installments, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":25000,"derivative":{"exercise_price":3.42,"expiration_date":"2027-07-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000904454-17-000523","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354718/000090445417000523/edgar.xml","form_type":"4"}},{"id":4272472,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":120873,"kind":"person","name":"Halak Brian K","position":1,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-26T16:20:22.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over twelve months, beginning one month after the date of grant, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.37,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000904454-17-000467","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000090445417000467/edgar.xml","form_type":"4"}},{"id":4353903,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157687,"kind":"organization","name":"DP VIII Associates, L.P.","position":1,"cik":"0001465143","reported_name":"DP VIII Associates, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Redeemable Convertible Preferred Stock","published_at":"2017-04-12T18:04:59.000Z","date":"2017-04-11","kind":"purchase","acquired":true,"shares":368,"price":100,"value":36800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Redeemable Convertible Preferred Stock is immediately convertible,  provided that such conversion would not cause the Reporting Person and its affiliates to beneficially own, in the aggregate, a number of shares of the Issuer's capital stock that represents in excess of 19.99% of the Issuer's voting power, subject to certain exceptions pursuant to the terms of the Redeemable Convertible Preferred Stock. The Redeemable Convertible Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Redeemable Convertible Preferred Stock is immediately convertible,  provided that such conversion would not cause the Reporting Person and its affiliates to beneficially own, in the aggregate, a number of shares of the Issuer's capital stock that represents in excess of 19.99% of the Issuer's voting power, subject to certain exceptions pursuant to the terms of the Redeemable Convertible Preferred Stock. The Redeemable Convertible Preferred Stock has no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"As managing members of the sole general partner of Domain Partners VIII, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by Domain Partners VIII, L.P., as reported on a Form 4 for Domain Partners VIII, L.P. filed on the same date as this Form 4."}],"balance_after":368,"derivative":{"exercise_price":3.19,"underlying":"Common Stock","underlying_shares":11536},"source":{"system":"sec-edgar","filing":"0000904454-17-000306","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000306/edgar.xml","form_type":"4"}},{"id":4354080,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":157686,"kind":"organization","name":"Domain Partners VIII, L.P.","position":1,"cik":"0001465144","reported_name":"Domain Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Redeemable Convertible Preferred Stock","published_at":"2017-04-12T17:49:49.000Z","date":"2017-04-11","kind":"purchase","acquired":true,"shares":49632,"price":100,"value":4963200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Redeemable Convertible Preferred Stock is immediately convertible,  provided that such conversion would not cause the Reporting Person and its affiliates to beneficially own, in the aggregate, a number of shares of the Issuer's capital stock that represents in excess of 19.99% of the Issuer's voting power, subject to certain exceptions pursuant to the terms of the Redeemable Convertible Preferred Stock. The Redeemable Convertible Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Redeemable Convertible Preferred Stock is immediately convertible,  provided that such conversion would not cause the Reporting Person and its affiliates to beneficially own, in the aggregate, a number of shares of the Issuer's capital stock that represents in excess of 19.99% of the Issuer's voting power, subject to certain exceptions pursuant to the terms of the Redeemable Convertible Preferred Stock. The Redeemable Convertible Preferred Stock has no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VIII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"As managing members of the sole general partner of DP VIII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VIII Associates, L.P., as reported on a Form 4 for DP VIII Associates, L.P. filed on the same date as this Form 4."}],"balance_after":49632,"derivative":{"exercise_price":3.19,"underlying":"Common Stock","underlying_shares":1555862},"source":{"system":"sec-edgar","filing":"0000904454-17-000304","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445417000304/edgar.xml","form_type":"4"}},{"id":4566961,"issuer":{"id":181299,"kind":"organization","name":"Tobira Therapeutics, Inc.","symbol":"TBRA"},"owners":[{"id":164155,"kind":"organization","name":"DOMAIN ASSOCIATES","position":1,"cik":"0001020733","reported_name":"DOMAIN ASSOCIATES","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":7,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-04T08:30:57.000Z","date":"2016-11-01","kind":"disposition_to_issuer","acquired":true,"shares":17695,"ownership":{"direct":false,"nature":"Held by Jesse I. Treu"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."}],"balance_after":0,"derivative":{"exercise_price":8.19,"underlying":"Common Stock","underlying_shares":17695},"source":{"system":"sec-edgar","filing":"0000904454-16-001535","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001535/edgar.xml","form_type":"4"}},{"id":4566960,"issuer":{"id":181299,"kind":"organization","name":"Tobira Therapeutics, Inc.","symbol":"TBRA"},"owners":[{"id":164155,"kind":"organization","name":"DOMAIN ASSOCIATES","position":1,"cik":"0001020733","reported_name":"DOMAIN ASSOCIATES","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":7,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-04T08:30:57.000Z","date":"2016-11-01","kind":"disposition_to_issuer","acquired":true,"shares":1071,"ownership":{"direct":false,"nature":"Held by Jesse I. Treu"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."}],"balance_after":0,"derivative":{"exercise_price":42.93,"underlying":"Common Stock","underlying_shares":1071},"source":{"system":"sec-edgar","filing":"0000904454-16-001535","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001535/edgar.xml","form_type":"4"}},{"id":4566959,"issuer":{"id":181299,"kind":"organization","name":"Tobira Therapeutics, Inc.","symbol":"TBRA"},"owners":[{"id":164155,"kind":"organization","name":"DOMAIN ASSOCIATES","position":1,"cik":"0001020733","reported_name":"DOMAIN ASSOCIATES","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":7,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-04T08:30:57.000Z","date":"2016-11-01","kind":"disposition_to_issuer","acquired":true,"shares":1996,"ownership":{"direct":false,"nature":"Held by Jesse I. Treu"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the merger described above, each outstanding option to purchase Common Stock which had an  exercise price less than $28.35 per share was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) $28.35 over (y) the exercise price per share, multiplied by (B) the total number of shares subject to such option immediately prior to the effective time of the merger and (ii) a contingent value right with respect to the total number of shares subject to such option immediately prior to the effective time of the merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each other outstanding option to purchase Common Stock was cancelled and converted into the right to receive a cash payment, if any, from Allergan Holdco US, Inc. with respect to each share subject to such option upon each date that a payment would be required to a holder of a contingent value right under the terms of the  contingent value rights agreement that was entered into in connection with the merger agreement on or prior to the fifth anniversary of the effective time of the merger."}],"balance_after":0,"derivative":{"exercise_price":36,"underlying":"Common Stock","underlying_shares":1996},"source":{"system":"sec-edgar","filing":"0000904454-16-001535","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001535/edgar.xml","form_type":"4"}},{"id":4566958,"issuer":{"id":181299,"kind":"organization","name":"Tobira Therapeutics, Inc.","symbol":"TBRA"},"owners":[{"id":164155,"kind":"organization","name":"DOMAIN ASSOCIATES","position":1,"cik":"0001020733","reported_name":"DOMAIN ASSOCIATES","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":30494,"kind":"person","name":"Kamdar Kim P.","position":7,"cik":"0001535065","reported_name":"Kamdar Kim P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-04T08:30:57.000Z","date":"2016-11-01","kind":"other","acquired":false,"shares":38094,"price":28.35,"value":1079964.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of a merger agreement, pursuant to which the Issuer was acquired by Allergan Holdco US, Inc., the shares were tendered for $28.35 per share in cash plus one non-transferable contingent value right per share, which represents the contractual right to receive one or more payments in cash of up to $49.84 per share in the aggregate, contingent upon the achievement of certain milestones."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly benefically owned by each of the Reporting Owners listed below, each of whom is a managing member of the designated Reporting Person.  Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-16-001535","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001535/edgar.xml","form_type":"4"}},{"id":4568480,"issuer":{"id":181299,"kind":"organization","name":"Tobira Therapeutics, Inc.","symbol":"TBRA"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-03T21:47:55.000Z","date":"2016-11-01","kind":"other","acquired":false,"shares":3553322,"price":28.35,"value":100736678.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of a merger agreement, pursuant to which the Issuer was acquired by Allergan Holdco US, Inc., the shares were tendered for $28.35 per share in cash plus one non-transferable contingent value right per share, which represents the contractual right to receive one or more payments in cash of up to $49.84 per share in the aggregate, contingent upon the achievement of certain milestones."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-16-001531","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001531/edgar.xml","form_type":"4"}},{"id":4568479,"issuer":{"id":181299,"kind":"organization","name":"Tobira Therapeutics, Inc.","symbol":"TBRA"},"owners":[{"id":181336,"kind":"organization","name":"DP VII ASSOCIATES LP","position":1,"cik":"0001372932","reported_name":"DP VII ASSOCIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-03T21:45:15.000Z","date":"2016-11-01","kind":"other","acquired":false,"shares":47613,"price":28.35,"value":1349828.55,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of a merger agreement, pursuant to which the Issuer was acquired by Allergan Holdco US, Inc., the shares were tendered for $28.35 per share in cash plus one non-transferable contingent value right per share, which represents the contractual right to receive one or more payments in cash of up to $49.84 per share in the aggregate, contingent upon the achievement of certain milestones."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000904454-16-001529","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001529/edgar.xml","form_type":"4"}},{"id":4579795,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":181336,"kind":"organization","name":"DP VII ASSOCIATES LP","position":1,"cik":"0001372932","reported_name":"DP VII ASSOCIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2016-10-14T12:04:58.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":14271,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of Domain Partners VII, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by Domain Partners VII, L.P., as reported on a Form 4 for Domain Partners VII, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14271},"source":{"system":"sec-edgar","filing":"0000904454-16-001502","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001502/edgar.xml","form_type":"4"}},{"id":4579794,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":181336,"kind":"organization","name":"DP VII ASSOCIATES LP","position":1,"cik":"0001372932","reported_name":"DP VII ASSOCIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2016-10-14T12:04:58.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":20583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of Domain Partners VII, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by Domain Partners VII, L.P., as reported on a Form 4 for Domain Partners VII, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20583},"source":{"system":"sec-edgar","filing":"0000904454-16-001502","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001502/edgar.xml","form_type":"4"}},{"id":4579793,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":181336,"kind":"organization","name":"DP VII ASSOCIATES LP","position":1,"cik":"0001372932","reported_name":"DP VII ASSOCIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2016-10-14T12:04:58.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":11083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of Domain Partners VII, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by Domain Partners VII, L.P., as reported on a Form 4 for Domain Partners VII, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14716},"source":{"system":"sec-edgar","filing":"0000904454-16-001502","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001502/edgar.xml","form_type":"4"}},{"id":4579792,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":181336,"kind":"organization","name":"DP VII ASSOCIATES LP","position":1,"cik":"0001372932","reported_name":"DP VII ASSOCIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-14T12:04:58.000Z","date":"2016-10-12","kind":"exercise","acquired":true,"shares":49570,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of Domain Partners VII, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by Domain Partners VII, L.P., as reported on a Form 4 for Domain Partners VII, L.P. filed on the same date as this Form 4."}],"balance_after":49570,"source":{"system":"sec-edgar","filing":"0000904454-16-001502","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001502/edgar.xml","form_type":"4"}},{"id":4579791,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2016-10-14T11:58:51.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":482326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VII Associates, L.P., as reported on a Form 4 for DP VII Associates, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":482326},"source":{"system":"sec-edgar","filing":"0000904454-16-001500","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001500/edgar.xml","form_type":"4"}},{"id":4579790,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2016-10-14T11:58:51.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":597207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VII Associates, L.P., as reported on a Form 4 for DP VII Associates, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":597207},"source":{"system":"sec-edgar","filing":"0000904454-16-001500","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001500/edgar.xml","form_type":"4"}},{"id":4579789,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2016-10-14T11:58:51.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":836722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VII Associates, L.P., as reported on a Form 4 for DP VII Associates, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":836722},"source":{"system":"sec-edgar","filing":"0000904454-16-001500","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001500/edgar.xml","form_type":"4"}},{"id":4579788,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2016-10-14T11:58:51.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":1206836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VII Associates, L.P., as reported on a Form 4 for DP VII Associates, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1206836},"source":{"system":"sec-edgar","filing":"0000904454-16-001500","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001500/edgar.xml","form_type":"4"}},{"id":4579787,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2016-10-14T11:58:51.000Z","date":"2016-10-12","kind":"exercise","acquired":false,"shares":649835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VII Associates, L.P., as reported on a Form 4 for DP VII Associates, L.P. filed on the same date as this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":862879},"source":{"system":"sec-edgar","filing":"0000904454-16-001500","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001500/edgar.xml","form_type":"4"}},{"id":4579786,"issuer":{"id":1824,"kind":"organization","name":"Vyome Holdings, Inc","symbol":"HIND"},"owners":[{"id":155584,"kind":"person","name":"DOMAIN PARTERS VII L P","position":1,"cik":"0001374150","reported_name":"DOMAIN PARTERS VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138386,"kind":"person","name":"BLAIR JAMES C","position":2,"cik":"0001024000","reported_name":"BLAIR JAMES C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153843,"kind":"person","name":"DOVEY BRIAN H","position":3,"cik":"0001207786","reported_name":"DOVEY BRIAN H","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":148535,"kind":"person","name":"TREU JESSE I","position":4,"cik":"0001013425","reported_name":"TREU JESSE I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79004,"kind":"person","name":"VITULLO NICOLE","position":5,"cik":"0001196863","reported_name":"VITULLO NICOLE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120873,"kind":"person","name":"Halak Brian K","position":6,"cik":"0001354718","reported_name":"Halak Brian K","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-14T11:58:51.000Z","date":"2016-10-12","kind":"exercise","acquired":true,"shares":3985970,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"As managing members of the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VII Associates, L.P., as reported on a Form 4 for DP VII Associates, L.P. filed on the same date as this Form 4."}],"balance_after":3985970,"source":{"system":"sec-edgar","filing":"0000904454-16-001500","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013425/000090445416001500/edgar.xml","form_type":"4"}}]}